Royalty Pharma
RPRX
#848
Rank
โ‚น2.598 T
Marketcap
โ‚น4,493
Share price
3.45%
Change (1 day)
70.71%
Change (1 year)

Revenue for Royalty Pharma (RPRX)

Revenue in 2025 (TTM): โ‚น208.13 Billion

According to Royalty Pharma's latest financial reports the company's current revenue (TTM ) is โ‚น222.72 Billion. an increase over the revenue in the year 2024 that were of โ‚น194.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Royalty Pharma from 2019 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น213.48 B9.94%
2024 โ‚น194.18 B-0.93%
2023 โ‚น196.01 B5.88%
2022 โ‚น185.12 B8.64%
2021 โ‚น170.40 B9.79%
2020 โ‚น155.21 B19.97%
2019 โ‚น129.37 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Abbott Laboratories
ABT
โ‚น4.151 T 1,763.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.104 T 2,640.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น77.44 B-65.23%๐Ÿ‡บ๐Ÿ‡ธ USA